Ethics/Regulatory

Biosimilars legislation approved in New Jersey

Wednesday, November 11, 2015

Legislation sponsored by Assembly Democrats of the New Jersey General Assembly (Pamela Lampitt, Daniel Benson, Shavonda Sumter, Nancy Pinkin, and Herb Conaway Jr., M.D.) to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer has been signed into law.

[Read More]

Veeva launches RIM Solution for regulatory documents

Wednesday, November 4, 2015

Veeva Systems, a cloud-based software provider for the global life sciences industry, has launched Veeva Vault RIM, a next-generation regulatory information management (RIM) suite. Vault RIM unites submission documents, published dossiers, product registrations and health authority interactions into a single authoritative source for all regulatory information. The convergence of RIM capabilities in Veeva Vault’s regulatory product suite will align disconnected regulatory processes worldwide, dramatically improving life sciences companies’ speed, agility and compliance.

[Read More]